Ronald DePinho, MD, President, The University of Texas MD Anderson Cancer Center
in conversation with Jeffrey O'Brien, Science & Technology Journalist
Dr. Ronald DePinho
Ronald DePinho is one of the world’s preeminent researchers on the molecular underpinnings of cancer and aging, and the translation of that knowledge into clinical advances. He was appointed president of the MD Anderson Cancer Center in Houston in 2011. Before that, he was a professor of medicine and genetics at Harvard Medical School for fourteen years and founding director of the Belfer Institute for Applied Cancer Science at the Dana-Farber Institute in Boston. He also co-chaired the advisory boards for the NCI Mouse Models of Human Cancers Consortium and the Cancer Genome Atlas Project. DePinho’s discoveries have been honored with a long list of awards—not to mention an appearance on The Colbert Report in January 2011, after his Harvard lab successfully reversed age degeneration in mice—and he was recently elected to both the National Academy of Sciences and the American Academy of Arts and Sciences.
Jeffrey O’Brien is a Science & Technology Journalist.
Ronald Depinho, President of the University of Texas's MD Anderson Cancer Center, argues that medical technology will be needed more than the Affordable Care Act to meet the growing needs of an aging population.